Myocardial Solutions Receives FDA clearance (K182756) on MyoStrain 6

Myocardial Solutions announces the release of MyoStrain 6, the latest iteration of its cutting-edge cardiac imaging software. Designed to enhance diagnostic precision and streamline clinical workflow, MyoStrain 6 introduces a suite of new features aimed at improving both ease of use and the depth of cardiac analysis.

MORRISVILLE, N.C., Nov. 19, 2024 Myocardial Solutions is proud to announce the release of MyoStrain 6, the latest iteration of its cutting-edge cardiac imaging software. Designed to enhance diagnostic precision and streamline clinical workflow, MyoStrain 6 introduces a suite of new features aimed at improving both ease of use and the depth of cardiac analysis.

MyoStrain 6.0 is set to redefine cardiac diagnostics with these innovative upgrades:

• Semi-Automated Contouring for Right Ventricle (RV): The addition of semi-automated RV contouring enables quicker assessments, allowing clinicians to focus on patient care by streamlining the exam process.
• 3D Strain Heart Visualization with Mid Myocardial Strain & Polar Plots: MyoStrain 6 now includes a fully interactive 3D strain model and dynamic Polar Plots, offering clinicians an immersive view of myocardial function and enhancing diagnostic insights.
• Traditional Global Measurements (TGM) for RV: This new functionality leverages 3D heart models to provide comprehensive and accurate RV measurements, enhancing measurement reliability and clinician confidence.
• Updated Stress GUI: The intuitive new stress interface integrates heart rate data with Stressed MyoHealth, delivering clearer insights into patients' cardiac response under stress conditions.
• Advanced Diagnostic Metrics: With the introduction of timing metrics and dyssynchrony indicators, MyoStrain 6 broadens diagnostic capabilities, offering CMR reviewers new tools for in-depth analysis.

Initial feedback from technicians and physicians point to improved user experience, ease of access to centralized information, and the benefits of having highly organized data.

MyoStrain 6 is available now in the US. For more information, visit www.myocardialsolutions.com or contact us at 919-677-8100.

About Myocardial Solutions

Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI's proprietary technology, MyoStrain®, is a 10-minute, MRI-based heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction.